BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

262 related articles for article (PubMed ID: 37947104)

  • 1. Clinical Characterization of the Persistent COVID-19 Symptoms: A Descriptive Observational Study in Primary Care.
    Rodríguez Onieva A; Vallejo Basurte C; Fernández Bersabé A; Camacho Cerro L; Valverde Bascón B; Muriel Sanjuan N; Soto Castro CA; García Morales V; Piedra Ruiz F; Hidalgo Requena A
    J Prim Care Community Health; 2023; 14():21501319231208283. PubMed ID: 37947104
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The presence of headache at onset in SARS-CoV-2 infection is associated with long-term post-COVID headache and fatigue: A case-control study.
    Fernández-de-Las-Peñas C; Gómez-Mayordomo V; Cuadrado ML; Palacios-Ceña D; Florencio LL; Guerrero AL; García-Azorín D; Hernández-Barrera V; Arendt-Nielsen L
    Cephalalgia; 2021 Nov; 41(13):1332-1341. PubMed ID: 34134526
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Estimated Global Proportions of Individuals With Persistent Fatigue, Cognitive, and Respiratory Symptom Clusters Following Symptomatic COVID-19 in 2020 and 2021.
    ; Wulf Hanson S; Abbafati C; Aerts JG; Al-Aly Z; Ashbaugh C; Ballouz T; Blyuss O; Bobkova P; Bonsel G; Borzakova S; Buonsenso D; Butnaru D; Carter A; Chu H; De Rose C; Diab MM; Ekbom E; El Tantawi M; Fomin V; Frithiof R; Gamirova A; Glybochko PV; Haagsma JA; Haghjooy Javanmard S; Hamilton EB; Harris G; Heijenbrok-Kal MH; Helbok R; Hellemons ME; Hillus D; Huijts SM; Hultström M; Jassat W; Kurth F; Larsson IM; Lipcsey M; Liu C; Loflin CD; Malinovschi A; Mao W; Mazankova L; McCulloch D; Menges D; Mohammadifard N; Munblit D; Nekliudov NA; Ogbuoji O; Osmanov IM; Peñalvo JL; Petersen MS; Puhan MA; Rahman M; Rass V; Reinig N; Ribbers GM; Ricchiuto A; Rubertsson S; Samitova E; Sarrafzadegan N; Shikhaleva A; Simpson KE; Sinatti D; Soriano JB; Spiridonova E; Steinbeis F; Svistunov AA; Valentini P; van de Water BJ; van den Berg-Emons R; Wallin E; Witzenrath M; Wu Y; Xu H; Zoller T; Adolph C; Albright J; Amlag JO; Aravkin AY; Bang-Jensen BL; Bisignano C; Castellano R; Castro E; Chakrabarti S; Collins JK; Dai X; Daoud F; Dapper C; Deen A; Duncan BB; Erickson M; Ewald SB; Ferrari AJ; Flaxman AD; Fullman N; Gamkrelidze A; Giles JR; Guo G; Hay SI; He J; Helak M; Hulland EN; Kereselidze M; Krohn KJ; Lazzar-Atwood A; Lindstrom A; Lozano R; Malta DC; Månsson J; Mantilla Herrera AM; Mokdad AH; Monasta L; Nomura S; Pasovic M; Pigott DM; Reiner RC; Reinke G; Ribeiro ALP; Santomauro DF; Sholokhov A; Spurlock EE; Walcott R; Walker A; Wiysonge CS; Zheng P; Bettger JP; Murray CJL; Vos T
    JAMA; 2022 Oct; 328(16):1604-1615. PubMed ID: 36215063
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Prevalence of post-acute COVID-19 syndrome symptoms at different follow-up periods: a systematic review and meta-analysis.
    Alkodaymi MS; Omrani OA; Fawzy NA; Shaar BA; Almamlouk R; Riaz M; Obeidat M; Obeidat Y; Gerberi D; Taha RM; Kashour Z; Kashour T; Berbari EF; Alkattan K; Tleyjeh IM
    Clin Microbiol Infect; 2022 May; 28(5):657-666. PubMed ID: 35124265
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Prevalence and determinants of persistent symptoms after infection with SARS-CoV-2: protocol for an observational cohort study (LongCOVID-study).
    Mutubuki EN; van der Maaden T; Leung KY; Wong A; Tulen AD; de Bruijn S; Haverman L; Knoop H; Franz E; van Hoek AJ; van den Wijngaard CC
    BMJ Open; 2022 Jul; 12(7):e062439. PubMed ID: 35777877
    [TBL] [Abstract][Full Text] [Related]  

  • 6. New daily persistent headache after SARS-CoV-2 infection in Latin America: a cross-sectional study.
    Carrión-Nessi FS; Ascanio LC; Pineda-Arapé AG; Omaña-Ávila ÓD; Mendoza-Millán DL; Romero SR; Almao-Rivero AB; Camejo-Ávila NA; Gebran-Chedid KJ; Rodriguez-Saavedra CM; Freitas-De Nobrega DC; Castañeda SA; Forero-Peña JL; Delgado-Noguera LA; Meneses-Ramírez LK; Cotuá JC; Rodriguez-Morales AJ; Forero-Peña DA; Paniz-Mondolfi AE
    BMC Infect Dis; 2023 Dec; 23(1):877. PubMed ID: 38097988
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Assessment of the Frequency and Variety of Persistent Symptoms Among Patients With COVID-19: A Systematic Review.
    Nasserie T; Hittle M; Goodman SN
    JAMA Netw Open; 2021 May; 4(5):e2111417. PubMed ID: 34037731
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Post-COVID-19 Symptoms 2 Years After SARS-CoV-2 Infection Among Hospitalized vs Nonhospitalized Patients.
    Fernández-de-Las-Peñas C; Rodríguez-Jiménez J; Cancela-Cilleruelo I; Guerrero-Peral A; Martín-Guerrero JD; García-Azorín D; Cornejo-Mazzuchelli A; Hernández-Barrera V; Pellicer-Valero OJ
    JAMA Netw Open; 2022 Nov; 5(11):e2242106. PubMed ID: 36378309
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Association of Age With Likelihood of Developing Symptoms and Critical Disease Among Close Contacts Exposed to Patients With Confirmed SARS-CoV-2 Infection in Italy.
    Poletti P; Tirani M; Cereda D; Trentini F; Guzzetta G; Sabatino G; Marziano V; Castrofino A; Grosso F; Del Castillo G; Piccarreta R; Andreassi A; Melegaro A; Gramegna M; Ajelli M; Merler S;
    JAMA Netw Open; 2021 Mar; 4(3):e211085. PubMed ID: 33688964
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Signs and symptoms to determine if a patient presenting in primary care or hospital outpatient settings has COVID-19.
    Struyf T; Deeks JJ; Dinnes J; Takwoingi Y; Davenport C; Leeflang MM; Spijker R; Hooft L; Emperador D; Domen J; Horn SRA; Van den Bruel A;
    Cochrane Database Syst Rev; 2021 Feb; 2(2):CD013665. PubMed ID: 33620086
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Incidence, co-occurrence, and evolution of long-COVID features: A 6-month retrospective cohort study of 273,618 survivors of COVID-19.
    Taquet M; Dercon Q; Luciano S; Geddes JR; Husain M; Harrison PJ
    PLoS Med; 2021 Sep; 18(9):e1003773. PubMed ID: 34582441
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Long COVID: Factors influencing persistent symptoms and the impact of gender.
    Rodríguez Onieva A; Soto Castro CA; García Morales V; Aneri Vacas M; Hidalgo Requena A
    Semergen; 2024 Mar; 50(5):102208. PubMed ID: 38471366
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Testing the efficacy and safety of BIO101, for the prevention of respiratory deterioration, in patients with COVID-19 pneumonia (COVA study): a structured summary of a study protocol for a randomised controlled trial.
    Dioh W; Chabane M; Tourette C; Azbekyan A; Morelot-Panzini C; Hajjar LA; Lins M; Nair GB; Whitehouse T; Mariani J; Latil M; Camelo S; Lafont R; Dilda PJ; Veillet S; Agus S
    Trials; 2021 Jan; 22(1):42. PubMed ID: 33430924
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Signs and symptoms to determine if a patient presenting in primary care or hospital outpatient settings has COVID-19 disease.
    Struyf T; Deeks JJ; Dinnes J; Takwoingi Y; Davenport C; Leeflang MM; Spijker R; Hooft L; Emperador D; Dittrich S; Domen J; Horn SRA; Van den Bruel A;
    Cochrane Database Syst Rev; 2020 Jul; 7(7):CD013665. PubMed ID: 32633856
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Prevalence and Predictors of Persistence of COVID-19 Symptoms in Older Adults: A Single-Center Study.
    Tosato M; Carfì A; Martis I; Pais C; Ciciarello F; Rota E; Tritto M; Salerno A; Zazzara MB; Martone AM; Paglionico A; Petricca L; Brandi V; Capalbo G; Picca A; Calvani R; Marzetti E; Landi F;
    J Am Med Dir Assoc; 2021 Sep; 22(9):1840-1844. PubMed ID: 34352201
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Prevalence of Post-COVID-19 Cough One Year After SARS-CoV-2 Infection: A Multicenter Study.
    Fernández-de-Las-Peñas C; Guijarro C; Plaza-Canteli S; Hernández-Barrera V; Torres-Macho J
    Lung; 2021 Jun; 199(3):249-253. PubMed ID: 33993321
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Symptomology following COVID-19 among adults in Alberta, Canada: an observational survey study.
    Chen X; Norris C; Whitten T; Ho C; Mann B; Bakal J
    BMJ Open; 2024 Mar; 14(3):e078119. PubMed ID: 38458800
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Burden of post-COVID-19 syndrome and implications for healthcare service planning: A population-based cohort study.
    Menges D; Ballouz T; Anagnostopoulos A; Aschmann HE; Domenghino A; Fehr JS; Puhan MA
    PLoS One; 2021; 16(7):e0254523. PubMed ID: 34252157
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Prevalence and determinants of post-acute sequelae of COVID-19 in Liberia.
    Gwaikolo C; Sackie-Wapoe Y; Badio M; Glidden DV; Lindan C; Martin J
    Int J Epidemiol; 2024 Feb; 53(1):. PubMed ID: 38052015
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Long-Term Symptoms after Mild Coronavirus Disease in Healthy Healthcare Professionals: A 12-Month Prospective Cohort Study.
    da Costa E Silva GR; Moura WÉA; Dos Santos KC; Gomes DO; Bandeira GN; Guimarães RA; Rosso CFW; Bazilio GS; Leite VRMC; Caetano KAA; Carneiro MADS; Teles SA
    Int J Environ Res Public Health; 2023 Jan; 20(2):. PubMed ID: 36674238
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.